INTECTAN Trademark

Trademark Overview

On Tuesday, August 4, 2009, a trademark application was filed for INTECTAN with the United States Patent and Trademark Office. The USPTO has given the INTECTAN trademark a serial number of 77796753. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 29, 2013. This trademark is owned by Biotest Pharmaceuticals Corporation. The INTECTAN trademark is filed in the Pharmaceutical Products category with the following description:

immune globulin for treatment of chronic immunodeficiency disease
intectan

General Information

Serial Number77796753
Word MarkINTECTAN
Filing DateTuesday, August 4, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 29, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 5, 2010

Trademark Statements

Goods and Servicesimmune globulin for treatment of chronic immunodeficiency disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 7, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiotest Pharmaceuticals Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33487
Party NameBiotest Pharmaceuticals Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoca Raton, FL 33487

Trademark Events

Event DateEvent Description
Monday, April 29, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 29, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 22, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 21, 2012EXTENSION 5 GRANTED
Monday, August 20, 2012EXTENSION 5 FILED
Monday, August 20, 2012TEAS EXTENSION RECEIVED
Wednesday, March 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2012EXTENSION 4 GRANTED
Friday, February 3, 2012EXTENSION 4 FILED
Friday, February 3, 2012TEAS EXTENSION RECEIVED
Thursday, August 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 10, 2011EXTENSION 3 GRANTED
Monday, August 8, 2011EXTENSION 3 FILED
Monday, August 8, 2011TEAS EXTENSION RECEIVED
Friday, February 4, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 3, 2011EXTENSION 2 GRANTED
Wednesday, February 2, 2011EXTENSION 2 FILED
Wednesday, February 2, 2011TEAS EXTENSION RECEIVED
Thursday, September 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2010EXTENSION 1 GRANTED
Thursday, August 19, 2010EXTENSION 1 FILED
Wednesday, September 15, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 19, 2010TEAS EXTENSION RECEIVED
Tuesday, March 30, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 5, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2010PUBLISHED FOR OPPOSITION
Monday, November 30, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 30, 2009ASSIGNED TO LIE
Thursday, November 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 9, 2009EXAMINER'S AMENDMENT ENTERED
Monday, November 9, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 9, 2009EXAMINERS AMENDMENT E-MAILED
Monday, November 9, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, November 6, 2009ASSIGNED TO EXAMINER
Friday, August 7, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 7, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

intectan immunodeficiency disease chronic treatment globulin immune